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The fluorescence of bacterial cells expressing a variant (GFPm) of
the green fluorescent protein (GFP) was reduced to background
levels by global replacement of the leucine residues of GFPm by
5,5,5-trifluoroleucine. Eleven rounds of random mutagenesis and
screening via fluorescence-activated cell sorting yielded a GFP
mutant containing 20 amino acid substitutions. Themutant protein
in fluorinated form showed improved folding efficiency both in
vivo and in vitro, and the median fluorescence of cells expressing
the fluorinated protein was improved 650-fold in comparison to
that of cells expressing fluorinated GFPm. The success of this
approach demonstrates the feasibility of engineering functional
proteins containing many copies of abiological amino acid constit-
uents.
directed evolution  noncanonical amino acids  protein engineering
The properties of proteins are strikingly susceptible to engi-neering via rational and combinatorial strategies (1–3). In
chemical terms, however, the engineering strategies used to date
are remarkably conservative, in that they use a common set of
20 ‘‘canonical’’ amino acid constituents. Recent work from
several laboratories has shown that a substantially expanded
repertoire of noncanonical amino acids can be incorporated into
recombinant proteins, either by amino acid replacement or by
nonsense or frameshift suppression (4–6). This work raises
intriguing questions about the prospects for creating novel
proteins by recruitment of new amino acid constituents. In
particular, global replacement of one of the canonical amino
acids by a noncanonical analog would be expected to cause
marked changes in protein structure, dynamics, and function. In
principle, such changes might be advantageous and might lead to
proteins of enhanced stability or reactivity (7–11). It seems
likely, however, that global replacement will in many cases
compromise protein folding and function (11–13), because both
protein structure and protein folding pathways have evolved in
a context defined by the canonical amino acid side chains.
Here we examine ‘‘reevolution’’ of the GFP after global
replacement of its Leu residues by 5,5,5-trif luoroleucine (Tfl).
Introduction of fluorinated amino acids into coiled-coil and
four-helix bundle proteins has been shown to cause substantial
increases in the stability of such proteins with respect to thermal
and chemical denaturation, as anticipated from the hyperhydro-
phobic character of fluorocarbons and the critical role of hy-
drophobic interactions in stabilizing native protein folds (7–9, 14,
15). On the other hand, global replacement of Leu by Tfl
destabilizes the more complex globular protein chloramphenicol
acetyltransferase (13).
GFP has been thoroughly studied in terms of structure,
spectral properties, stability, and folding behavior (15–28) and is
an attractive target for evolutionary studies, because its inherent
fluorescence permits high-throughput analysis and screening of
mutant libraries via fluorescence activated cell sorting. GFP
contains 238-aa residues, 19 of which are Leu. Global replace-
ment of Leu by Tfl causes misfolding of GFP and loss of
fluorescence emission. Here we show that reevolution of the
fluorinated protein restores proper folding and yields a fluori-
nated variant that exhibits physical and spectroscopic behavior
nearly identical to that of wild-type GFP.
Results and Discussion
Two mutations (S65G and S72A) (19) were introduced into
cycle-3 GFP (Q80R, F99S, M153T, and V163A) (20) to render
its spectral properties appropriate for cell sorting [see supporting
information (SI Text) for plasmid construction and SI Fig. 4].
The resulting GFP variant (GFPm) was expressed in media
depleted of Leu and supplemented with 1 mM Tfl (7). The
protein was purified under denaturing conditions, and the extent
of replacement of Leu by Tfl was determined to be 78% by
MALDI-MS (SI Fig. 5) and 77% by amino acid analysis (AAA).
Replacement of Leu by Tfl caused a reduction of 500-fold in
the median fluorescence of cells expressing the fluorinated
protein (Fig. 1 and SI Table 2), such that the observed fluores-
cence was comparable to that characteristic of cells lacking the
gene coding for GFP (data not shown).
GFP fluorescence is produced by a chromophore formed by a
spontaneous reaction involving residues 65–67 in the interior of
the -barrel structure; the chromophore forms only after the
protein folds into a nearly native conformation (17). To deter-
mine whether the reduction in fluorescence observed upon
introduction of Tfl into GFPm is caused by aberrant protein
folding or by inhibition of chromophore formation within a
properly folded protein framework, the solubility of the ex-
pressed proteins was examined. Although nearly all of the GFPm
made with Leu in the medium (GFPm-L) was present in the cell
lysate in soluble form, that made with Tfl (GFPm-T) was almost
entirely insoluble (Fig. 2 B and C). This result suggests that the
observed reduction in fluorescence is most probably a conse-
quence of misfolding and aggregation of the fluorinated form of
GFPm.
To determine whether it is possible to recover properly folded
fluorinated variants of GFP, we applied a directed evolution
approach involving randomization of the sequence of GFPm by
error-prone PCR, expression of mutants in media depleted of
Leu and supplemented with Tfl, and selection of highly fluo-
rescent mutants by cell sorting. During the initial rounds of
screening under these conditions, however, no improvement
of fluorescence was observed; clones tested after several rounds
of sorting exhibited only background fluorescence. The low
fluorescence of cells expressing fluorinated proteins (which was
comparable to the background autofluorescence of Escherichia
coli) hindered the use of media devoid of Leu as the starting
point for directed evolution. Instead, we adopted a procedure in
which, for the first few rounds of evolution, a small amount of
Leu was added to the medium during protein expression. Several
different concentrations of Leu were tested for the first library
(SI Fig. 6); 45MLeu was used for protein expression. After two
rounds of sorting, the cell population was enriched in fluorescent
Author contributions: T.H.Y. and D.A.T. designed research; T.H.Y. performed research;
T.H.Y. and D.A.T. analyzed data; and T.H.Y., A.J.L., and D.A.T. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Abbreviations: Tfl, 5,5,5-trifluoroleucine; AAA, amino acid analysis.
*To whom correspondence should be addressed. E-mail: tirrell@caltech.edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/
0701904104/DC1.
© 2007 by The National Academy of Sciences of the USA
www.pnas.orgcgidoi10.1073pnas.0701904104 PNAS  August 28, 2007  vol. 104  no. 35  13887–13890
CH
EM
IS
TR
Y
variants (SI Fig. 7), and four of seven randomly selected clones
showed enhanced fluorescence (data not shown). Using the
plasmid DNA from this pool of sorted cells, we prepared a
second randomized library. The Leu concentration was reduced
during expression of the second-generation library (SI Table 3),
and from the fourth generation forward, we added no Leu to the
expression medium (SI Table 3).
Eleven rounds of directed evolution yielded a variant of GFP
(11.3.3) containing 20-aa substitutions (SI Table 4). Clones are
designated by three digits. The first is the library generation
number, the second is the number of times the library was sorted,
and the third is the number of the clone isolated from the
library). The median fluorescence of cells that express this
variant in fluorinated form (11.3.3-T) is increased 650-fold
over that of cells expressing GFPm-T and higher than that of
cells expressing GFPm-L (Fig. 1 and SI Table 2). Two more
mutants, 4.2.2 from the fourth-generation library and 8.3.3 from
the eighth-generation library, were chosen for comparison (Fig.
1 and SI Table 4). Although we found a significant increase in
the fluorescence of cells between generations four and eight,
only minor improvements were observed in the last three rounds
of evolution (compare 8.3.3 and 11.3.3). The fluorescence of
cells that express GFP variants in media containing the 20
canonical amino acids also increased, as shown by comparing the
median fluorescence of cells expressing 11.3.3-L with that of cells
expressing GFPm-L (Fig. 1B).
The increase in cell f luorescence can be attributed to an
increase in the amount of properly folded, soluble, functional
protein in the cell as well as to changes in the spectral properties
of the protein. The amount of soluble protein depends both on
the expression level and on the fraction of the expressed protein
that remains soluble. Both the expression level and the soluble
fraction increased as the evolution progressed (Fig. 2). As
mentioned previously, the soluble fraction of GFPm-T was
negligible; in contrast, the majority of 11.3.3-T was present in
soluble form. The photophysical properties of the purified
proteins were also improved by evolution (Table 1). GFPm-T
was not characterized, because it formed inclusion bodies, and
our attempts to refold the denatured protein were unsuccessful.
11.3.3-T exhibited significant increases in extinction coefficient
and quantum yield as compared with 4.2.2-T, and its brightness
(defined as the product of extinction coefficient and quantum
yield) is 1.6-fold higher than that of GFPm-L. The values of the
absorption and emission maxima, extinction coefficient, quan-
tum yield, and pKa differ slightly for the Leu and Tfl forms of
each protein variant, suggesting small changes in the environ-
ment around the chromophore (16–18). The oligomerization
states of GFPm, 11.3.3-L, and 11.3.3-T were determined by
sedimentation velocity analysis (see SI Text for experimental
details). Although GFPm-L was characterized by monomer-
dimer self-association with Kd  23 M, both 11.3.3-L and
11.3.3-T were primarily dimeric in the concentration range
studied. We found no evidence that Tfl stimulates aggregation
of the protein. Taken together, these results suggest that the
100 101 102 103 104
Relative fluorescence (a.u.)
C
el
l c
o
u
n
t
C
el
l c
o
u
n
t
100 101 102 103 104
Relative fluorescence (a.u.)
C
el
l c
o
u
n
t
C
el
l c
o
u
n
t
A
B
Fig. 1. Flow cytometric analysis of GFPm and GFP variants. Proteins were
expressed in media depleted of Leu and supplemented with Tfl (A) or in media
containing all 20 canonical amino acids (B). Black line, GFPm; blue line, 4.2.2;
gray line, 8.3.3; and red line, 11.3.3.
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Fig. 2. Expression level and solubility in vivo of GFPm and GFP variants. (A)
SDS/PAGE of whole-cell lysates after IPTG induction for 3 h. (BandC) SDS/PAGE
of crude cell lysate pellets (P) and supernatants (S). The proteins were ex-
pressed in media depleted of Leu and supplemented with Tfl (B) or in media
containing all 20 canonical amino acids (C). The arrows indicate the expected
size of GFPm or GFP variants.
13888  www.pnas.orgcgidoi10.1073pnas.0701904104 Yoo et al.
primary consequence of the evolutionary process is an enhance-
ment in the folding behavior of the fluorinated protein.
To explore this conjecture more directly, we examined the
refolding kinetics of each protein after acid denaturation (23,
24). Each variant was denatured in 100 mM citrate buffer (pH
1.9, 2 mM DTT), and the recovery of fluorescence was moni-
tored upon 100-fold dilution into 20 mM Tris buffer (pH 8.0, 100
mM NaCl/1 mM DTT) (SI Fig. 8). The refolding rate was
markedly enhanced by evolution (Table 1 and Fig. 3B), to the
extent that 11.3.3-T and GFPm-L refold at comparable rates.
The refolding rates of the Leu forms of the protein are also
enhanced; 11.3.3-L folds faster than both GFPm-L and 11.3.3-T.
The directed evolution strategy adopted here yielded a flu-
orinated GFP variant (11.3.3-T) with physical and spectroscopic
properties comparable to those of GFPm-L. It is interesting,
however, that although the screening was done in Leu-depleted
media, the properties of the Leu form of the protein also
improved (albeit far less than those of the Tfl form). This fact
suggests that the acquired mutations not only accommodate the
replacement of Leu by Tfl but also improve the folding prop-
erties of GFP irrespective of Tfl incorporation. Indeed, four of
the mutations found here (S30R, Y145F, I171V, and A206V)
were recently reported to improve the folding efficiency of GFP
and to contribute to the development of a ‘‘superfolder’’ variant
of the protein (25). Pe´delacq et al. (25) developed the super-
folder variant by fusing GFP to a poorly folded protein (bullfrog
red-cell H-subunit ferritin) and then evolving the fusion con-
struct to enhance folding behavior (25). Although our objectives
and approach differ from those of Pedelacq et al. (25), Tfl also
inhibits GFP folding, and it is perhaps not surprising that we
would acquire mutations that enhance folding behavior in other
contexts. 11.3.3-L and superfolder GFP both exhibit increased
expression levels (Fig. 2C), improved folding kinetics (Table 1
and Fig. 3) and enhanced resistance to chemical denaturation (SI
Fig. 9). Noncanonical amino acids may prove generally useful
tools for improving the folding behavior of proteins.
The replacement of Leu by other canonical amino acids at six
positions in 11.3.3 (L42I, L53I, L119I, L194R, L207I, and
L221H) suggests there may be sites at which Tfl cannot be
accommodated through compensating mutations. Four Leu
residues (L42, L53, L119, and L207) that point toward the inside
of the -barrel [in the structure of wild-type GFP (21)] were
mutated to Ile, whereas two surface-exposed Leu positions
(L194 and L221) (21) are occupied by hydrophilic residues in the
evolved mutant.
There are also two sites at which new Leu residues were added
to the sequence (F46L and S202L). F46L has been reported to
increase the maturation rate of the chromophore of yellow
fluorescent protein (26); Tfl at position 46 may play a similar
role. Among the remaining mutations, only two (F64C and
Y106F) are located in the hydrophobic core; the rest are exposed
on the outer surface of the -barrel. The F64C mutation
immediately precedes the chromophore, and it is known that an
alternative mutation at this position (F64L) improves the mat-
uration of GFP at 37°C (27). Intentional introduction of a Leu
codon at position 64 of 11.3.3 led to a significant decrease in the
brightness of the fluorinated form of the protein (SI Fig. 10).
Evolution of the fluorinated protein selects Cys rather than Tfl
at position 64.
Conclusions
The results reported here show that simple directed evolution
strategies, combined with global incorporation of noncanonical
amino acids, can produce properly folded functional proteins of
novel composition. Replacement of the Leu residues of GFP by
Tfl causes misfolding of the protein in the bacterial cell, probably
as a consequence of the increased hydrophobic character of the
fluorinated Tfl side chains. Directed evolution of the fluorinated
protein yields 20 mutations, eliminating six Leu sites but intro-
ducing two others; the evolved mutant carries fluorinated side
chains at 15 positions and exhibits physical and spectroscopic
properties nearly identical to those of the parent GFPm. The
evolutionary process also improved the folding behavior of the
Leu form of the protein, suggesting that noncanonical amino
acids may be useful in evolving folding behavior more generally.
Table 1. Photophysical properties and refolding kinetitcs of GFPm and GFP variants
Clone abs ()* em (QY)*
Relative
brightness† pKa
Refolding kinetic parameters
Percentage Tfl
by AAA¶
k1,
101 s1‡
k2,
102 s1‡ A1§ A2§
GFPm-L 503 (84) 509 (0.42) 1 6.7 1.5 3.4 0.36 0.64 —
4.2.2-L 507 (127) 511 (0.60) 2.2 6.2 1.9 3.3 0.37 0.63 —
4.2.2-T 500 (56) 509 (0.28) 0.44 6.9 0.55 1.1 0.47 0.53 78
8.3.3-L 507 (133) 512 (0.67) 2.5 5.7 2.1 4.1 0.56 0.44 —
8.3.3-T 503 (103) 510 (0.53) 1.6 6.0 0.86 3.1 0.47 0.53 85
11.3.3-L 505 (147) 510 (0.61) 2.5 5.6 1.8 3.3 0.58 0.42 —
11.3.3-T 501 (114) 509 (0.48) 1.6 6.0 0.94 2.6 0.57 0.43 87
QY, fluorescence quantum yield.
*Absorption and emission maxima are expressed in nanometers; the extinction coefficient () is expressed in 103 M1cm1.
†Relative brightness was calculated as the product of  and QY divided by the brightness of GFPm-L.
‡Rate constants for double-exponential fits of the refolding curves.
§Relative magnitude of each component of the refolding process.
¶Percentage of replacement of Leu by Tfl as determined by AAA.
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Fig. 3. Representative plots of refolding kinetics after acid denaturation for
GFPm-L (blue), 4.2.2-T (black), 11.3.3-L (aqua), and 11.3.3-T (red). Inset plots
show the early stages of the refolding process.
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Materials and Methods
Construction of Randomly Mutated GFPm Libraries. A Stratagene
GeneMorph random mutagenesis kit was used to generate
GFPm libraries according to the manufacturer’s protocol by
using primers FP (5-CTTTCGTCTTCACCTCGAG-3) and
RP (5-CTCCATTTTAGCTTCCTTAGCTC-3) with pQE-
80L/GFPm as template. The targeted mutation rate was two to
four mutations per gene in each library. The PCR product was
purified on a 1% agarose gel and digested with BamHI and
HindIII. The resulting DNA fragment was purified on a 1%
agarose gel and ligated into BamHI/HindIII-digested pQE-80L
by using T4 DNA ligase. The ligated product was transformed
into E. coli strain DH10B by electroporation. After overnight
culture in LB medium supplemented with 200 mg/liter ampicil-
lin, the cells were stored in 25% glycerol at 80°C.
Protein Expression.M9medium supplemented with 0.4% glucose/
3.5 mg/liter thiamine/1 mM MgSO4/0.1 mM CaCl2/20 amino
acids (40 mg/liter)/200 mg/liter ampicillin was inoculated 1/100
with an overnight culture (M9) of E. coli strain DH10B trans-
formed with mutants or libraries. After each culture reached
OD600  0.9–1.0, the cells were harvested by centrifugation
(6,000  g, 4°C, 6 min) and washed twice with cold 0.9% NaCl.
The cell pellets were resuspended in supplemented M9 medium
containing 19 amino acids (no Leu) and 1 mM Tfl. As discussed
in the text, a small amount of Leu was added to the media in early
rounds of evolution (SI Table 3) to control the level of incor-
poration of Tfl. Protein expression was induced 10 min after the
medium shift by addition of IPTG to a final concentration of 1
mM. After 3 h, the cells were harvested by centrifugation
(6,000  g, 4°C, 10 min). The harvested cells were washed twice
with 10 mM phosphate buffer (pH 7.4) containing 100 mMNaCl
(PBS) and resuspended in PBS to 0.05 OD600 for flow cyto-
metric analysis and cell sorting. Alternatively, the cells were
stored at 80°C.
Flow Cytometric Analysis and Cell Sorting. All flow cytometric
analyses and cell sorting were carried out on a DakoCytomation
MoFlo cell sorter (DakoCytomation, Ft. Collins, CO) equipped
with an argon ion laser emitting at 488 nm and a 530/40 bandpass
filter. The throughput rate of cells was adjusted to 20,000–30,000
events per second, and108 cells were sorted in singlemode.Agate
in the fluorescence channel was set to recover 0.3–0.5%of themost
highly fluorescent cells. Additional gates were set in the forward-
and side-scatter channels to exclude events arising from large
particles. The sorted cells were incubatedwith 2ml of super optimal
broth plus glucose (SOC) medium at 37°C for 1 h and then diluted
with 20 ml of LB medium supplemented with 200 mg/liter ampi-
cillin. After overnight growth at 37°C, the cells were stored in 25%
glycerol at 80°C.
Purification of GFPm and GFP Variants. N-terminally histidine-
tagged GFP mutants were purified by affinity chromatography
by using Ni-NTA resin (Qiagen, Chatsworth, CA) according to
the manufacturer’s protocols. Proteins purified under native
conditions were precipitated by adding ammonium sulfate to
80% saturation. The pellets were resuspended with PBS and
desalted on PD-10 columns (GE Healthcare, Piscataway, NJ), as
recommended by the manufacturer.
AAA, Molar Extinction Coefficients, Quantum Yield, and pKa. AAA
was performed at the W. M. Keck Facility at Yale University
(New Haven, CT) on a Beckman Model 7300 ion-exchange
instrument (Beckman, Fullerton, CA), after 16-h hydrolysis at
115°C in HCl (100 ml/6 M/0.2% phenol) that also contained
norleucine (2 nmol). The concentration of purified proteins
was measured by using the BCA assay kit (Pierce, Rockford,
IL). Each f luorescent protein was diluted to four different
concentrations, and the absorbance was measured at the
excitation maximum. Beer’s law was used to determine the
extinction coefficient from the slope of the plots of absorbance
vs. protein concentration. The molar mass of f luorinated
protein was calculated by using the extent of incorporation of
Tf l measured by AAA. Quantum yields were determined by
comparison of the integrated spectrum of each protein (480–
600 nm emission; excitation at 470 nm) to that of f luorescein
in 100 mM sodium borate (pH 9.5) (Molecular Probes, Eu-
gene, OR; quantum yield  0.93). The pKa values of the
proteins were determined as described (28).
Refolding Kinetics. Proteins were unfolded in 100 mM citrate (pH
1.9) containing 2 mM DTT at room temperature for 1 h. The
denatured protein solution was diluted 100-fold into 20 mM Tris
(pH 8.0)/100 mM NaCl/1 mM DTT. Refolding was monitored by
recovery of chromophore fluorescence at 510 nmwith excitation at
490 nm. The data were fitted to double-exponential functions by
using Origin software (OriginLab, Northampton, MA). We also
examined refolding after denaturation in urea solutions; in our
hands, however, acid denaturation afforded the most reproducible
refolding kinetics.
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